Effect of rituximab on heart involvement in systemic sclerosis
As of now, there has been a great body of data on the use of rituximab (RTM) in systemic sclerosis (SS), mainly on its positive effect on skin fibrosis and lung injury. However, information is still scarce about the effect of RTM on other organs and systems, namely the heart affected by SS.Objective...
Saved in:
| Main Authors: | L. A. Garzanova, L. P. Ananyeva, O. A. Koneva, O. B. Ovsyannikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2019-01-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2646 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal function during long-term therapy with rituximab in patients with systemic sclerosis
by: M. N. Starovoitova, et al.
Published: (2023-10-01) -
Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab
by: L. P. Ananieva, et al.
Published: (2020-09-01) -
Safety and tolerability of rituximab in the treatment of systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2023-04-01) -
The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2023-08-01) -
Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
by: E. N. Harlamova, et al.
Published: (2021-01-01)